As I sat through the many DTC presentations last week at The DTC National Conference I took note of the people actually creating DTC. They all struck me as passionate about their products and their customers. While it is easy to be cynical about the drug companies as corporate entities it is harder when you […]
DTC Perspectives Announces the 2017 Ad Award Winners at Annual National Conference
The leading forum for direct-to-consumer (DTC) advertising thought leaders honored a dynamic group of pharmaceutical companies and brands at the much-anticipated DTC National Advertising Awards. The awards were part of the 17th Annual DTC National Conference held April 5-7 in Boston. Sponsored by Health Monitor Network, the 2017 Advertising Awards showcased the best marketing and advertising […]
DTC in Perspective: The Healthcare Compromise We Need
The basic problem in American politics today is we are asked choose a side. Either we are supposed love Obamacare or hate it depending on our political affiliation. That we somehow must think Obamacare has been either a savior or villain is the fault of our self serving politicians. Both sides are equally to blame. […]
Overcoming Communication Obstacles to Patient Engagement and Adherence
While the primary focus of patient adherence programs today has shifted from the product to the patient, the communication barriers that hinder patient interaction and engagement are still common. Many of these barriers can be overcome by investigating and addressing the root causes of issues, which often occur in either the basic program design […]
DTC in Perspective: The Power of Peers
We all know about patient support forums. I am sure most of us check one forum or another about a condition we or a loved one have. Only recently did I have an occasion to see how powerful patient to patient sites are in influencing treatment and thought about how important it is to integrate […]
DTC in Perspective: Nielsen Says Record 2016 DTC Spending
The final 2016 spending was released recently showing $5.66 billion versus $5.18 in 2015. DTC Perspectives has received some detail on these numbers and we ran some analysis explaining the growth. In 2014 spending was $4.33 billion so the last two years has seen growth of 31%. The 2016 number was a record and we […]
DTC in Perspective: Times of Turmoil Ahead
While we are seeing record $ 5.6 billion spending numbers for DTC for 2016, we are also seeing a populist tide raging against drug companies. At the upcoming DTC National a few weeks from now we will be spending a lot of time on the forces that may affect the health of DTC in the […]
DTC in Perspective: The DTC Hunters Are Active
Every year I seem to need to rebut a critic of DTC who proposes a ban. Google DTC advertising and every month there will be call for a ban in the media. These DTC Hunters think that by making it extinct great things will happen. First, they believe prices for drugs would drop dramatically if […]
Beyond the Moustache: PatientPoint Takes The Movember Foundation to Point of Care
On February 17th, the Movember Foundation went beyond the moustache by expanding their promotional efforts through PatientPoint. With prostate cancer now the second most common form of cancer seen in men in the U.S., the two organizations teamed up to spread awareness and inspire healthy action between men and their healthcare professionals. According to Paul […]
DTC in Perspective: Media Misreporting Advertising Off-label Use
I was shocked to see media stories saying DTC may expand to cover off label use. What! This erroneous idea came from an FDA open meeting held 11/16 to discuss off label use based on court cases allowing drug companies the right to discuss them. FDA has been under pressure on first amendment grounds to […]